Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teriflunomide (Aubagio) approved for use by the NHS in Scotland and Northern Ireland
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Ofatumumab Dose-finding in RRMS Patients
Arzerra
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
Fourth Cooperative Meeting of Consortium of MS Centers and Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
LKB1-regulated adaptive mechanisms are essential for neuronal survival following mitochondrial dysfunction.
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.
TGN1412: From Discovery to Disaster.
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis.
Mechanical environment modulates biological properties of oligodendrocyte progenitor cells.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
Biogen Idec's PLEGRIDY™ (peginterferon beta-1a) approved in the US for the treatment of multiple sclerosis
Thrombotic microangiopathy associated with interferon beta.
New insights into signaling during myelination in zebrafish.
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.

Pages